Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Norristown, Pennsylvania 19403


Purpose:

The primary objective of this study is to compare the total costs to sites and payers of administering IV iron over the 30-day observation period for subjects with IDA who receive Ferric Carboxymaltose (FCM) relative to those who receive iron sucrose, iron dextran, and ferumoxytol.


Study summary:

The primary objective of this study is to compare the total costs to sites and payers of administering IV iron over the 30-day observation period for subjects with IDA who receive Ferric Carboxymaltose (FCM) relative to those who receive iron sucrose, iron dextran, and ferumoxytol.


Criteria:

Inclusion Criteria: - Must present for the first dose of a current cycle of IV treatment for IDA - Must be over 18 years of age - Must be willing and able to provide informed consent, including permission to obtain information from their medical records. - Must be able to read and understand English. Exclusion Criteria: - Subjects not diagnosed with IDA. - Subjects requiring more than one treatment cycle within 30 days. - Subjects receiving maintenance IV iron therapy. - Subjects treated with IV iron within the 30-day period prior to study enrollment. - Subjects who received investigational medication in the six months prior to the study.


NCT ID:

NCT01984554


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Norristown, Pennsylvania 19403
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 21, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.